Medline Inc. Announces Voluntary Field Action & Market Exit of Medline Brand Beds with Estimated Costs up to $220M

Summary of Event

On October 14, 2026, Medline Inc. (NASDAQ: MDLN) initiated a voluntary field action encompassing the removal, discontinuation, and full market exit of all Medline Brand beds. The discontinuation impacts homecare beds, bariatric beds, and long-term care beds, as well as associated pendants, accessories, replacement parts, and bed-containing order packages.

The affected products reside within the Front Line Care product category of the company's Medline Brand reporting segment.

Financial Implications

• Historical Revenue: Net sales of the affected bed lines totaled approximately $60 million for the twelve-month period ended June 27, 2026.
• Estimated Costs: The company estimates total associated costs of up to $220 million, spanning inventory impairment, disposal expenses, and customer credits. These expenses are expected to be recognized over fiscal years 2026 and 2027.
• Adjusted EBITDA Treatment: All related charges will be excluded from the company's Adjusted EBITDA metric.
• Guidance Outlook: Management indicated that it does not expect this action to have a material impact on its fiscal year 2026 financial results or its full-year guidance previously provided on August 5, 2026.